Two Sigma Investments »

Sonnet Biotherapeutc Hldng I shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $69k 15k 4.58
2024-12-31 $28k 19k 1.46

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Sonnet Biotherapeutc Hldng I

Ikarian Capital
Vanguard Group
Hrt Financial
Geode Capital Management
Boothbay Fund Management
Goldman Sachs Group
Citadel Advisors
Virtu Financial
State Street Corporation
BlackRock
Northern Trust
Two Sigma Investments
Investment House
Jane Street
Jpmorgan Chase & Co

View all funds holding Sonnet Biotherapeutc Hldng I